Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Health Catalyst (HCAT) Operating Expenses (2018 - 2025)

Historic Operating Expenses for Health Catalyst (HCAT) over the last 8 years, with Q3 2025 value amounting to $55.3 million.

  • Health Catalyst's Operating Expenses rose 1591.97% to $55.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $239.3 million, marking a year-over-year increase of 792.56%. This contributed to the annual value of $210.6 million for FY2024, which is 1860.82% down from last year.
  • According to the latest figures from Q3 2025, Health Catalyst's Operating Expenses is $55.3 million, which was up 1591.97% from $75.3 million recorded in Q2 2025.
  • Health Catalyst's 5-year Operating Expenses high stood at $77.7 million for Q3 2022, and its period low was $47.7 million during Q3 2024.
  • For the 5-year period, Health Catalyst's Operating Expenses averaged around $62.7 million, with its median value being $61.9 million (2021).
  • Per our database at Business Quant, Health Catalyst's Operating Expenses soared by 7303.05% in 2021 and then crashed by 2723.23% in 2023.
  • Over the past 5 years, Health Catalyst's Operating Expenses (Quarter) stood at $75.6 million in 2021, then fell by 10.32% to $67.8 million in 2022, then decreased by 6.65% to $63.3 million in 2023, then fell by 17.54% to $52.2 million in 2024, then increased by 6.0% to $55.3 million in 2025.
  • Its Operating Expenses stands at $55.3 million for Q3 2025, versus $75.3 million for Q2 2025 and $56.4 million for Q1 2025.